Correlation Between Milestone Pharmaceuticals and HCW Biologics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and HCW Biologics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and HCW Biologics.
Diversification Opportunities for Milestone Pharmaceuticals and HCW Biologics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Milestone and HCW is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and HCW Biologics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and HCW Biologics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 8.15 times less return on investment than HCW Biologics. But when comparing it to its historical volatility, Milestone Pharmaceuticals is 16.6 times less risky than HCW Biologics. It trades about 0.28 of its potential returns per unit of risk. HCW Biologics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 45.00 in HCW Biologics on August 29, 2024 and sell it today you would earn a total of 11.00 from holding HCW Biologics or generate 24.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. HCW Biologics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| HCW Biologics |
Milestone Pharmaceuticals and HCW Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and HCW Biologics
The main advantage of trading using opposite Milestone Pharmaceuticals and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.The idea behind Milestone Pharmaceuticals and HCW Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Scpharmaceuticals | HCW Biologics vs. Milestone Pharmaceuticals | HCW Biologics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |